GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Sale Of Investment

MDBIF (TrivarX) Sale Of Investment : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Sale Of Investment?

TrivarX's sale of investment for the six months ended in Dec. 2024 was $0.00 Mil. It means TrivarX gained $0.00 Mil from selling investments. TrivarX's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), TrivarX gained the same money from selling investments in Dec. 2024 ($0.00 Mil).


TrivarX Sale Of Investment Historical Data

The historical data trend for TrivarX's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Sale Of Investment Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 - - - -

TrivarX Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TrivarX Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Sale Of Investment Related Terms

Thank you for viewing the detailed overview of TrivarX's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Provides Updated Company Presentation

By Marketwired Marketwired 10-05-2018

Medibio Provides Market Update

By Marketwired Marketwired 09-10-2018

Medibio Announces Scientific Advisory Board

By Marketwired Marketwired 04-26-2018

Medibio Announces Executive Leadership Changes

By Marketwired Marketwired 09-21-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018

Medibio Submits FDA De Novo Application

By Marketwired Marketwired 07-16-2018

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Medibio Receives TGA Approval

By Marketwired Marketwired 06-19-2018